Haemonetics to Present at Raymond James 44th Annual Institutional Investors Conference

Rhea-AI Summary

Haemonetics Corporation (NYSE: HAE) has announced that President and CEO Chris Simon will engage with investors during a fireside chat at the Raymond James 44th Annual Institutional Investors Conference on March 6, 2023, at 8:40 a.m. ET. The chat will be accessible via a live webcast on Haemonetics' Investor Relations website. After the event, a replay will be available for 90 days. Haemonetics specializes in innovative medical products aimed at improving patient care and lowering healthcare costs across critical medical markets, including blood and plasma collection.

News Market Reaction – HAE

-2.75%

-2.75% Session move

In the trading session that priced this news, HAE declined 2.75%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BOSTON, Feb. 27, 2023 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will participate in a fireside chat with investors at the Raymond James 44th Annual Institutional Investors Conference on Monday, March 6, 2023, at 8:40 a.m. ET.

The public may access a live webcast of the fireside chat at Haemonetics' Investor Relations website or at: https://wsw.com/webcast/rj127/hae/1443508. A replay of the recorded webcast will become accessible 12 hours after the event and will be available for 90 days on Haemonetics' Investor Relations website.

ABOUT HAEMONETICS

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.

Investor Contacts:
Olga Guyette, Sr. Director-Investor Relations & Treasury
(781) 356-9763
olga.guyette@haemonetics.com

David Trenk, Manager-Investor Relations
(203) 733-4987 
david.trenk@haemonetics.com

Media Contact: 
Josh Gitelson, Director-Global Communications
(781) 356-9776
josh.gitelson@haemonetics.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-to-present-at-raymond-james-44th-annual-institutional-investors-conference-301757058.html

SOURCE Haemonetics Corporation

FAQ

When will Chris Simon participate in the fireside chat for Haemonetics?

Chris Simon will participate in the fireside chat on March 6, 2023, at 8:40 a.m. ET.

How can I access the webcast of the Haemonetics investor fireside chat?

The webcast can be accessed on Haemonetics' Investor Relations website or directly at https://wsw.com/webcast/rj127/hae/1443508.

How long will the recorded webcast of the Haemonetics event be available?

The recorded webcast will be available for 90 days after the event.

What is Haemonetics' primary focus in the healthcare sector?

Haemonetics focuses on innovative medical products and solutions for blood and plasma collection, surgical suites, and hospital transfusion services.